Go to start page
V1.6.10 T351
R748016bfc
Disclaimer & Information
Search
Show Mindmap
 
Poisonous animals
 
Cnidarians (Jellyfish, Corals and Anemones)
 
Venomous fish
 
Scorpions
 
Spiders
 
Hymenopterans (Bees, Wasps and Ants)
 
Sea snakes
 
Terrestrial snakes
 
Miscellaneous animals
 
North America
 
Mexico and Central America
 
South America and the West Indies
 
Europe
 
North Africa, Near and Middle East
 
Central and Southern Africa
 
The Far East
 
Indian Subcontinent and Southeast Asia
 
Australia and the Pacific Islands
 
 
 
 
 
 
 
 

Diagnosis & Treatment — General practitioner / health post

 

General problems

At particular risk are: children, elderly people, patients with pre-existing conditions, such as coronary heart disease, arterial hypertension, lung disease, kidney disease, allergies (sensitisation), patients with predilection sites for bleeding such as gastrointestinal ulcers, kidney stones, pulmonary cavities (tuberculous), and patients taking particular drugs, such as coumarin derivatives, platelet aggregation inhibitors and beta-blockers.

Patient presents with a tourniquet on the affected extremity

D  Diagnostics

Check venous and arterial blood supply in the extremity.

C  Comments

If a tourniquet has been applied, it should not be removed until antivenom is at hand and the means for treating complications, including possible complications caused by the antivenom, are available.

If these requirements cannot be met within a suitable period of time, it is necessary to weigh the risk of the systemic effects of the venom that could occur after removing the tourniquet against the risk of progressive local tissue damage that may arise if the bandage is left in place.

Is it likely that a clinically relevant injection of venom has taken place?

D  Diagnostics

Inquire re:

  • time of the bite,
  • local pain,
  • nausea, vomiting, abdominal pain.

Assess:

  • state of consciousness.

Measure:

  • blood pressure/pulse,
  • respiratory rate.

Observe/investigate:

  • bite marks,
  • extent and intensity of local swelling,
  • enlargement and painfulness of regional lymph nodes,
  • swelling in the facial region, including the larynx/pharynx (angio-oedema),
  • clinical signs of shock,
  • bleeding from bite marks and other injuries,
  • subcutaneous bleeding in the region of the swelling,
  • gingival bleeding,
  • blood-stained sputum, vomit ("coffee ground vomitus"), stools (melaena) or urine,
  • acute abdomen (intra-abdominal bleeding!),
  • focal neurological deficits, meningismus (intracranial bleeding!),
  • cranial nerve deficits, such as ptosis, ophthalmoplegia, dysphagia, dysarthria,
  • paralysis of the skeletal musculature including the respiratory musculature (→ respiratory insufficiency/respiratory failure),
  • flank pain and renal bed sensitive to percussion.

Determine:

  • cause of the accident by determination of specific venom antigen and venom concentration in the serum using the ELISA method (if clinically proven and standardised test kits are commercially available), 
  • clotting time (bedside test),
  • urinary output.
C  Comments

The symptoms and degree of envenoming depend not only on the amount of venom injected and numerous other variables, but also on the time that has elapsed since the bite. This variable factor must be taken into account when making the following decisions:

  • exclusion of envenoming (see below),
  • the time interval between clinical examinations (see Therapy phase: Hospital),
  • emergency care (see below).

The fact that a patient has been bitten by a known venomous snake and the presence of bite marks do not automatically allow the conclusion that a clinically relevant injection of venom has taken place.

On the other hand, local signs, e.g. swelling at the site of the bite, following crotalid bites are an indication that a significant injection of venom has occurred. There do, however, appear to be exceptions (see Diagnosis and treatment: Terrestrial snakes: North America: Hospital).

In contrast to the Crotalus durissus subspecies from the southern regions of the distribution area of this species, those in the north (now Crotalus simus) cause strong local effects. Following Micrurus sp. bites, however, local effects such as swelling are minimal or absent.

Noticeable bleeding may be absent during the initial phase or the entire course of envenoming following crotalid bites, even though defibrinogenation may be present to such a degree that the blood is completely incoagulable (clotting time test). This is true in particular for those species whose venom primarily contains components that have direct fibrinogen-coagulating activity ("thrombin-like" activity).

The simple clotting time test should always be performed if a crotalid bite is suspected.

Exclusion of clinically relevant envenoming

D  Diagnostics

Monitoring for signs and symptoms (see above) that would indicate systemic envenoming for at least 24 h (recommended examinations, see Therapy phase: Hospital).

Preparalytic phase:

Elapids (Micrurus sp.): from 30–60 min to several hours, in some cases >12 h.

Preclinical phase of haemostatic defects:

Crotalids: systemic bleeding can occur within the first hour after the bite. Even severe haemostatic defects that can be detected on laboratory tests may not become clinically evident for a long period or even not at all. However, on laboratory investigations (clotting time), haemostatic defects can become apparent as early as <1 h after the bite (Rosenfeld 1971), although they may also appear after a delay of several hours.

 

C  Comments

The absence of signs of envenoming in the first hours after the bite does not exclude the possibility that a relevant injection of venom has taken place. There can be a long delay before systemic signs of envenoming develop.

Who requires antivenom?

D  Diagnostics

Antivenom indications (overview)
Systemic signs of envenoming:

  • (acute) arterial hypotension,
  • (persistent) arterial hypotension,
  • haemostatic defects (clinically, laboratory parameters: clotting time or more complex tests),
  • cranial nerve deficits (ptosis, ophthalmoplegia, dysphagia, dysarthria),
  • paralysis of the limb musculature,
  • paralysis of the respiratory musculature (→ respiratory insufficiency/failure),
  • acute renal failure.

Local signs of envenoming:

  • In the case of (rapidly) progressive or already marked swelling, especially following bites by those species of snakes known to cause necrosis.

How is the appropriate antivenom chosen?

D  Diagnostics

How are antivenoms administered and complications caused by antivenoms treated?

T  Treatment
C  Comments

Symptomatic emergency medical treatment and antivenom treatment are complementary strategies.

The aim of antivenom treatment is neutralisation of the venom. The success of antivenom treatment depends on the quality of the antivenom, the specific properties of those venom components relevant to envenoming and the time point at which antivenom is administered.

Symptomatic emergency medical treatment
1. Clinical signs of shock.

S  Signs & Symptoms

Very early: anaphylactic/anaphylactoid shock (uncommon).

T  Treatment
  • Treatment of the anaphylactic/anaphylactoid shock,
  • possibly antivenom.
S  Signs & Symptoms

Early (within hours): generalised fluid sequestration caused by increased capillary permeability → hypovolaemic shock. 

T  Treatment
  • Treatment of the hypovolaemia/hypovolaemic shock,
  • antivenom.
S  Signs & Symptoms

Extensive swelling, entire extremity, possibly also involving the trunk (fluid sequestration caused by increased capillary permeability) hypovolaemic shock.

T  Treatment
  • Treatment of the hypovolaemia/hypovolaemic shock,
  • antivenom.
S  Signs & Symptoms

Usually late (hours to days after the bite): clinical signs of extensive blood loss → haemorrhagic shock (uncommon).

T  Treatment
  • Treatment of the haemorrhagic shock,
  • antivenom.

Symptomatic emergency medical treatment
2. Clinical signs of progressive paralysis; paralysis of the respiratory musculature (→ dyspnoea, respiratory failure).

T  Treatment

Symptomatic emergency medical treatment
3. Clinical signs of focal neurological deficits, meningismus (intracranial bleeding!).

T  Treatment
  • Treatment of the intracranial bleeding,
  • antivenom.
C  Comments

Symptomatic emergency medical treatment and antivenom treatment are complementary strategies.

The aim of symptomatic emergency medical treatment is the rapid correction of critical parameters (fluid balance, blood pressure, oxygenation etc.) and the maintenance of vital functions (respiratory, cardiovascular).

Symptomatic measures help bridge the gap until specific treatment (antivenom) can be administered and starts being effective. If no antivenom is available or if the required effect is not achieved with antivenom, the goal is to employ symptomatic measures until such time as the venom naturally starts losing its activity. 
It is essential to correct arterial hypotension as quickly as possible. It is often the consequence of hypovolaemia and hypoproteinaemia caused by fluid sequestration in the bitten and subsequently swollen extremity. Large volumes of intravascular fluid replacement may be necessary.

Local treatment

Bite wound, including the surrounding reaction

D  Diagnostics
  • Assessment of the wound according to the usual criteria.
  • Swelling: assessment of the extent and increase in magnitude; regional signs of haemorrhage.
  • Long-term: observation for the formation of necrosis (see Therapy phase: Hospital: Follow-up).
T  Treatment
  • Cleaning, disinfection and dressing of the wound at regular intervals.
  • Immobilisation of the extremity with a splint. Padding and monitoring to prevent pressure necrosis and disturbance of the blood circulation if the oedema increases.
  • Possibly also prophylactic antibiotic treatment:
    • no interference with the bite wound: penicillin or erythromycin,
    • bite wound has been interfered with (incisions etc.): penicillin or erythromycin + aminoglycoside (Warrell 1990b).

Tetanus

T  Treatment

Tetanus prophylaxis.